Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2200062233Phase 4Not yet recruiting
Phase 4 trial of mepivacaine, lidocaine and propofol in arrhythmogenic cardiomyopathy (ACM) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Amount of propofol. Planned start Aug 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2200062233.